Research and Markets (http://www.researchandmarkets.com/research/pxrt4w/spinal_cord) has announced the addition of the "Spinal Cord Disorders-Pipeline Insights, 2014" subscription to their offering.
This Spinal Cord Disorders-Pipeline Insights report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Spinal Cord Disorders.
This report provides information on the therapeutic development based on the Spinal Cord Disorders dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information.
The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.
Key Topics Covered:
- Spinal Cord Disorders Overview
- Spinal Cord Disorders Pipeline Therapeutics
- Spinal Cord Disorders Therapeutics under Development by Companies
- Spinal Cord Disorders Late Stage Products (Filed and Phase III)
- Comparative Analysis
- Spinal Cord Disorders Mid Clinical Stage Products (Phase II)
- Comparative Analysis
- Spinal Cord Disorders Early Clinical Stage Products (Phase I and IND Filed)
- Comparative Analysis
- Spinal Cord Disorders Discovery and Pre-Clinical Stage Products
- Comparative Analysis
- Drug Candidate Profiles
- Spinal Cord Disorders - Therapeutics Assessment
- Assessment by Monotherapy Products
- Assessment by Combination Products
- Assessment by Route of Administration
- Assessment by Molecule Type
- Spinal Cord Disorders - Discontinued Products
- Spinal Cord Disorders - Dormant Products
- Companies Involved in Therapeutics Development for Spinal Cord Disorders
- Appendix
For more information visit http://www.researchandmarkets.com/research/pxrt4w/spinal_cord
Contacts:
Laura Wood, Senior Manager
press@researchandmarkets.com
For
E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S.
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals